doi,标题,期刊,年份,作者
10.1158/1538-7445.AM2019-CT103,Low-dose daunorubicin to target leukemia stem cells in newly diagnosed and relapsed/refractory AML,CANCER RESEARCH,2019,"Tara L. Lin,John M. Perry,Xi He,Gregory Reed,Na Zhang,Scott Weir,Joseph McGuirk,Linheng Li"
10.1158/1538-7445.sabcs18-ct103,Abstract CT103: Low-dose daunorubicin to target leukemia stem cells in newly diagnosed and relapsed/refractory AML,Clinical Trials,2019,"Tara L. Lin,John M. Perry,Xi He,Gregory Reed,Na Zhang,Scott Weir,Joseph McGuirk,Linheng Li"
10.1158/1538-7445.AM2018-CT137,Biomarkers Of Response To Leukemia Stem Cell Targeted Therapy With Low Dose Daunorubicin In Relapsed/Refractory Acute Leukemia,CANCER RESEARCH,2018,"Tara L. Lin,John M. Perry,Xi He,Gregory Reed,Na Zhang,Scott Weir,Joseph P. Mcguirk,Linheng Li"
10.1158/1538-7445.am2018-ct137,Abstract CT137: Biomarkers of response to leukemia stem cell targeted therapy with low dose daunorubicin in relapsed/refractory acute leukemia,Cancer Research,2018,"Tara L. Lin,John M. Perry,Xi C. He,Gregory A. Reed,Na Zhang,Scott Weir,Joseph McGuirk,Linheng Li"
,Treatment With Low-Dose Daunorubicin Reduces The Number Of Leukemia Stem Cells In Patients With Relapsed/Refractory Acute Myeloid Leukemia,BLOOD,2017,"Tara L. Lin,John M. Perry,Xi He,Raymond P. Perez,Gregory Reed,Margaret M. Brophy,Na Zhang,Scott Weir,Joseph P. Mcguirk,Linheng Li"
